iBio Inc (FRA:0JV0)
€ 3.5145 0 (0%) Market Cap: 23.66 Mil Enterprise Value: 14.64 Mil PE Ratio: 0 PB Ratio: 1.16 GF Score: 34/100

Q4 2022 Ibio Inc Earnings Call Transcript

Sep 27, 2022 / 08:30PM GMT
Release Date Price: €430
Operator

Thank you for standing by and welcome to the iBio Fiscal Year 2022 Results Conference Call.

At this time, all participants are in a listen-only mode. After the speakers' presentation, a question and answer session (inaudible). To ask a question at that time, please press star-one-one on your touchtone telephone.

As a reminder, today's conference call is being recorded.

I will now turn the conference to your host, Mr. Stephen Kilmer with Investor Relations. Please go ahead.

Stephen Kilmer
Investor Relations - iBio, Inc.

Thank you. Good afternoon, everyone. Before we begin, I would like to remind you that during this call, the company will be making forward-looking statements regarding our current expectations and projections about future events that are subject to risks and uncertainties. Refence to these risks and uncertainties are made in today's press release, and the close and details in the company's periodic and current filings with the U.S. Securities and Exchange Commission.

No forward-looking statements can be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot